{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:18:26Z","timestamp":1784326706177,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Bladder cancer (BLCA) remains heavily dependent on bacillus Calmette-Gu\u00e9rin (BCG) therapy due to the profound heterogeneity of its tumor microenvironment (TME) and deregulated metabolic landscapes. Taurine metabolism (TM) is a pivotal axis in BLCA, exhibiting dual roles in tumor progression and immune evasion. Deciphering the molecular mechanisms by which TM reprogramming fosters immunosuppression is imperative for advancing BLCA immunotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study employed an integrative approach combining single-cell RNA sequencing (scRNA-seq), spatial transcriptomics (ST), and bulk transcriptome analyses to unravel taurine metabolic dysregulation in the BLCA TME. Computational frameworks such as Seurat and Monocle 3 were used to characterize cellular subpopulations, reconstruct differentiation trajectories, and model intercellular signaling networks. A taurine metabolic dysregulation index (TMs) was developed using TCGA cohorts, with survival modeling and machine learning methodologies deployed to assess its prognostic utility. Immuno-infiltration patterns and immunotherapeutic responsiveness were quantified via algorithms including ESTIMATE and TIDE. Mechanistic validation was achieved through co-culture systems.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ScRNA-seq profiling revealed significant perturbations in TM scores across epithelial cells, fibroblasts, and macrophages within the BLCA TME. High TMs clusters were enriched for Notch signaling and EGFR tyrosine kinase inhibitor resistance pathways. Spatial transcriptomics analyses highlighted spatiotemporal heterogeneity in taurine metabolic gene expression. The TMs index emerged as an independent prognostic biomarker, with high TMs patients demonstrating significantly shorter overall survival and synergistic prognostic deterioration in the context of high tumor mutational burden (TMB). High TMs tumors exhibited enrichment of immunosuppressive cell compartments and elevated immune checkpoint molecule expression. Mechanistically, FAAH knockdown in cancer-associated fibroblasts (CAFs) attenuated co-cultured BLCA cell viability, potentially mediated by CCL15 secretion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study establishes that taurine metabolic dysregulation reconfigures intercellular signaling within the BLCA TME, driving immunosuppression and tumor progression. The TMs framework enables robust patient stratification and provides a mechanistic rationale for therapeutic strategies targeting TM in conjunction with immune checkpoint inhibitors, thus paving the way for advanced precision medicine approaches in BLCA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1618439","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:20:47Z","timestamp":1750742447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Taurine-mediated metabolic immune crosstalk indicates and promotes immunosuppression with anti-PD-1 resistance in bladder cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhengfang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwei","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e2407715","DOI":"10.1002\/advs.202407715","article-title":"Tracing the evolution of sex hormones and receptor-mediated immune microenvironmental differences in prostate and bladder cancers: from embryonic development to disease","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.08.001","article-title":"Bladder-sparing therapy for bacillus calmette-gu\u00e9rin-unresponsive non-muscle-invasive bladder cancer: international bladder cancer group recommendations for optimal sequencing and patient selection","volume":"86","author":"Li","year":"2024","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0019423","DOI":"10.1128\/cmr.00194-23","article-title":"Review of BCG immunotherapy for bladder cancer","volume":"38","author":"Liatsos","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1186\/s12967-024-05963-5","article-title":"Unraveling the interplay of CD8\u2009+\u2009T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches","volume":"22","author":"Zabeti Touchaei","year":"2024","journal-title":"J Transl Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133323","article-title":"Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer","volume":"274","author":"Qin","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41419-024-06837-w","article-title":"The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies","volume":"15","author":"Yu","year":"2024","journal-title":"Cell Death Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1537808","article-title":"Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12943-024-02095-8","article-title":"Programmed death receptor (PD-)1\/PD-ligand (L)1 in urological cancers: the \u201call-around warrior\u201d in immunotherapy","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03697-w","article-title":"Tumor microenvironment as a complex milieu driving cancer progression: a mini review","volume":"27","author":"Li","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.v44.10","article-title":"FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies","volume":"44","author":"Noeraparast","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12026-025-09624-7","article-title":"Phenotypic characterization of tumor associated macrophages and circulating monocytes in patients with Urothelial carcinoma of bladder","volume":"73","author":"Singh","year":"2025","journal-title":"Immunol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1235884","article-title":"The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition","volume":"14","author":"van Dorp","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043788","article-title":"Taurine and creatine transporters as potential drug targets in cancer therapy","volume":"24","author":"Stary","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/nu15194236","article-title":"Functional role of taurine in aging and cardiovascular health: an updated overview","volume":"15","author":"Santulli","year":"2023","journal-title":"Nutrients"},{"key":"B15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41577-024-01032-6","article-title":"Tumour cell consumption of taurine exhausts CD8(+) T cells","volume":"24","author":"Flemming","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3892\/mmr.2021.12242","article-title":"Protective role of taurine against oxidative stress (Review)","volume":"24","author":"Baliou","year":"2021","journal-title":"Mol Med Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00726-024-03440-3","article-title":"Taurine prevents mitochondrial dysfunction and protects mitochondria from reactive oxygen species and deuterium toxicity","volume":"57","author":"Seneff","year":"2025","journal-title":"Amino Acids"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508730","article-title":"Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15725-8","article-title":"Recent advances of neoadjuvant immunotherapy for urothelial bladder cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2723264","DOI":"10.1155\/2022\/2723264","article-title":"IL1RN and PRRX1 as a prognostic biomarker correlated with immune infiltrates in colorectal cancer: evidence from bioinformatic analysis","volume":"2022","author":"Wang","year":"2022","journal-title":"Int J Genomics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12920-023-01688-4","article-title":"Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma","volume":"16","author":"Zhao","year":"2023","journal-title":"BMC Med Genomics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2301801","DOI":"10.1080\/15384047.2024.2301801","article-title":"The critical role of tumor microbiome in cancer immunotherapy","volume":"25","author":"Yang","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020288","article-title":"Role of bladder cancer metabolic reprogramming in the effectiveness of immunotherapy","volume":"13","author":"Scholtes","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.455","article-title":"Targeted therapies in bladder cancer: signaling pathways, applications, and challenges","volume":"4","author":"Peng","year":"2023","journal-title":"MedComm (2020)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3892\/ijmm.2023.5282","article-title":"Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review)","volume":"52","author":"Zhang","year":"2023","journal-title":"Int J Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314808","article-title":"The involvement of long non-coding RNAs in glutamine-metabolic reprogramming and therapeutic resistance in cancer","volume":"23","author":"Roh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/jca.94360","article-title":"Decoding gastric cancer: machine learning insights into the significance of COMMDs family in immunotherapy and diagnosis","volume":"15","author":"Wan","year":"2024","journal-title":"J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"van Puffelen","year":"2020","journal-title":"Nat Rev Urol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00212-24","article-title":"BCG therapy in bladder cancer and its tumor microenvironment interactions","volume":"38","author":"Jian","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2018.04.010","article-title":"Metabolic changes in bladder cancer","volume":"36","author":"Woolbright","year":"2018","journal-title":"Urol Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","article-title":"Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8(+) T cells","volume":"187","author":"Cao","year":"2024","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1618439\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:20:48Z","timestamp":1750742448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1618439\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2025.1618439"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1618439","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1618439"}}